Clinical trials
Active, not recruiting Observational Carcinoma, Renal Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 2 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Duke University | 2 |
| First Affiliated Hospital of Fujian Medical University | 2 |
| Ipsen | 2 |
| Tianjin Medical University Second Hospital | 2 |
| Bristol-Myers Squibb | 1 |
| Centre of Postgraduate Medical Education | 1 |
| Elephas | 1 |
| Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 1 |
| Fox Chase Cancer Center | 1 |
| Indiana University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Renal Cell | 18 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Kidney Neoplasms | 3 |
| Melanoma | 3 |
| Neoplasm Metastasis | 2 |
| Urinary Bladder Neoplasms | 2 |
| Carcinoma | 1 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Squamous Cell | 1 |
| Carcinoma, Transitional Cell | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.